Is this you?
Request access for Skin Care Research with your @skincareresearch.org work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Intera lens
ICP 6Lift (cardio sample) 0.07Recruit soph 0.43
Quality Scorecard (1–100)
Overall74Recruit57Ops81Sponsor80Ther80
Performance (observed)
Historical trials
364
Completed
194
Terminated/Withdrawn
22
Completion rate
90%
Active now
141
Phase 2
120
Phase 3
193
Realized enrollment
207,057
First study year
2003
Years active
23
Match confidence
high
Enrollment velocity (inf)
9,002
Therapeutic
Areas
Dermatology (Clinical & Cosmetic)
Specialties
Dermatology: acne, rosacea, psoriasis, eczema, vitiligo, cosmetic
Breadth (conditions)
590
Languages
English
States
FL, TX
Recruitment (web observed)
Trial Finder
Yes
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Y (dermatology content)
Capability notes
Over 25 years experience, board-certified dermatologists, multiple locations close to patient populations, active recruitment for multiple trials
Relationships
Sponsors
AbbVie; Pfizer; Eli Lilly and Company; National Cancer Institute (NCI); Amgen; Alliance for Clinical Trials in Oncology
CROs
Acrotech Biopharma Inc.
Partnerships
Affiliated dermatology practices
Owner / parent
Unknown
Funding
Private
Expansion
Hollywood FL + Boca Raton FL; 25+ years experience
Capacity & people
Investigators
—
Coordinators
—
CEO
Unknown
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Tech & DCT
Builds tech
Unknown
Tech stack
No specific platforms mentioned
Recruiting visible
Y
Notes
Moderate fit: 25+ years experience, specialized in dermatology with multiple sites (FL + TX), 10+ actively recruiting studies visible on website. Strong recruitment visibility (advertises prominently). Dermatology is moderate-volume area. Sites spread across FL and TX suggests network approach. Risk: limited leadership visibility, narrow therapeutic focus, no tech innovation mentioned.
Recommendation features (sample indication)
Ind fit 0.12Liftability 0.07Overall74
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.